Recall Atlas
Drugs & medicalClass II

Boehringer Ingelheim Pharmaceuticals, Inc. recalls Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets…

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Read the official notice →
Date
2026-07-08
Country
United States
Brand
Boehringer Ingelheim Pharmaceuticals
Product
Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only,…
Classification
Class II
Units
OH
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Boehringer Ingelheim Pharmaceuticals recalls

  1. 2023-03-29
  2. US
    Drugs & medicalClass II

    Boehringer Ingelheim Pharmaceuticals, Inc. recalls JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC…

    Labeling: Label Mix-up

    FDA · DrugBoehringer Ingelheim Pharmaceuticals, Inc.Product was distributed nationwide within the United States and PROfficial notice →
All 2 Boehringer Ingelheim Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2026-07-08
  2. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for:…

    cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

    FDA · DrugCipla USA, Inc.USA NationwideOfficial notice →
  3. US
    Drugs & medicalClass II

    Lannett Company Inc. recalls Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release…

    Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

    FDA · DrugLannett Company Inc.US Nationwide.Official notice →
  4. US
    Drugs & medicalClass II

    Asclemed USA Inc. recalls Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem…

    Lack of Assurance of Sterility

    FDA · DrugAsclemed USA Inc.USA NationwideOfficial notice →
  5. US
    Drugs & medicalClass II

    ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC…

    Subpotent Drug

    FDA · DrugACCORD HEALTHCARE, INC.US Nationwide.Official notice →
  6. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls prednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only, Sterile, a) 5 mL (NDC 70748-332-02); b) 10 mL (NDC 70748-332-03), c) 15…

    Presence of Foreign Substance

    FDA · DrugLupin Pharmaceuticals Inc.U.S. NationwideOfficial notice →
  7. US
    Drugs & medicalClass III

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc.,…

    Failed Impurities/Degradation Specifications

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCU.S. NationwideOfficial notice →
See all drugs & medical recalls →